Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy IGM Biosciences stock
Learn how to easily invest in IGM Biosciences stock.
IGM Biosciences Inc is a biotechnology business based in the US. IGM Biosciences shares (IGMS) are listed on the NASDAQ and all prices are listed in US Dollars. IGM Biosciences employs 217 staff and has a trailing 12-month revenue of around $366,000.
How to buy shares in IGM Biosciences
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – IGMS – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
IGM Biosciences stock price (NASDAQ: IGMS)Use our graph to track the performance of IGMS stocks over time.
IGM Biosciences shares at a glance
|Latest market close||$19.43|
|52-week range||$12.67 - $74.60|
|50-day moving average||$20.23|
|200-day moving average||$20.03|
|Wall St. target price||$42.80|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-5.52|
Buy IGM Biosciences shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy IGM Biosciences stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
IGM Biosciences price performance over time
|1 week (2022-09-23)||1.20%|
|1 month (2022-09-01)||-2.26%|
|3 months (2022-07-01)||5.77%|
|6 months (2022-03-28)||N/A|
|1 year (2021-10-01)||-70.52%|
|2 years (2020-10-01)||-74.48%|
|3 years (2019-10-01)||9.90%|
|5 years (2017-09-27)||N/A|
IGM Biosciences financials
|Gross profit TTM||$-39,161,000|
|Return on assets TTM||-27.61%|
|Return on equity TTM||-58.84%|
|Market capitalisation||$819 million|
TTM: trailing 12 months
IGM Biosciences share dividends
We're not expecting IGM Biosciences to pay a dividend over the next 12 months.
IGM Biosciences share price volatility
Over the last 12 months, IGM Biosciences's shares have ranged in value from as little as $12.67 up to $74.6. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while IGM Biosciences's is -0.3368. This would suggest that IGM Biosciences's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, IGM Biosciences has bucked the trend.
IGM Biosciences overview
IGM Biosciences, Inc. , a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non-Hodgkin's lymphoma (NHL). It is also developing IGM-8444, an IgM antibody, which is in Phase 1 clinical trials for the treatment of patients with solid cancers; and IGM-7354, an anti-PD-L1 IgM antibody for the treatment of patients with solid and hematologic malignancies; IGM-2644, a bispecific T cell engaging IgM antibody targeting CD38 and CD3 proteins for the treatment of patients with multiple myeloma; and IGM-2537, a bispecific T cell engaging IgM antibody targeting CD123 and CD3 proteins for the treatment of patients with acute myeloid leukemia, myelodysplastic syndromes, and acute lymphoblastic leukemia. It has a collaboration and license agreement with Genzyme Corporation to generate, develop, manufacture, and commercialize IgM antibodies. The company was formerly known as Palingen, Inc. and changed its name to IGM Biosciences, Inc.
IGM Biosciences in the news
IGM Biosciences to Present at Three Upcoming Investor Conferences
IGM Biosciences to Present at Three Upcoming Investor Conferences
Frequently asked questionsWhat percentage of IGM Biosciences is owned by insiders or institutions?
Currently 38.753% of IGM Biosciences shares are held by insiders and 62.885% by institutions. How many people work for IGM Biosciences?
Latest data suggests 217 work at IGM Biosciences. When does the fiscal year end for IGM Biosciences?
IGM Biosciences's fiscal year ends in December. Where is IGM Biosciences based?
IGM Biosciences's address is: 325 East Middlefield Road, Mountain View, CA, United States, 94043 What is IGM Biosciences's ISIN number?
IGM Biosciences's international securities identification number is: US4495851085 What is IGM Biosciences's CUSIP number?
IGM Biosciences's Committee on Uniform Securities Identification Procedures number is: 449585108
More guides on Finder
How to buy YanGuFang International Group (YGF) stock when it goes public
Everything we know about the YanGuFang International Group IPO, plus information on how to buy in.
What are the FAANG stocks and how do you invest in them?
Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.
How to buy soccer stocks
A simple guide to buying stocks in your favorite European soccer team.
How to buy Juventus stock
Steps to owning and managing JUVE, with 24-hour and historical pricing before you buy.
How to buy AS Roma stock
Steps to owning and managing ASR, with 24-hour and historical pricing before you buy.
How to buy Borussia Dortmund stock
Steps to owning and managing BVB, with 24-hour and historical pricing before you buy.
How to buy Lead Real Estate Co. (LRE) stock when it goes public
Everything we know about the Lead Real Estate Co. IPO, plus information on how to buy in.
How to buy Third Harmonic Bio (THRD) stock
Everything we know about the Third Harmonic Bio IPO, plus information on how to buy in.
How to buy LINKBANCORP (LNKB) stock
Everything we know about the LINKBANCORP IPO, plus information on how to buy in.
Here are the stocks that benefit from inflation, as well as industries to keep an eye on to reduce the impacts of inflation on your portfolio.
Ask an Expert